ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.844,28
-0,33%
S&P 500
5.881,63
-0,43%
Dow Jones
42.544,22
-0,07%
Euro vs US Dollar
1,033
-0,20%
Bitcoin
96.586,76
2,33%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Nexalin Technologies Inc (NXL) Börsenkurse

Nexalin Technologies Inc

Nexalin Technologies Inc (NXL)

Nuix Limited
2,76
-0,06
(-2,13%)
Geschlossen 01 Januar 10:00PM
Verzögert um 15 Minuten
2,76
0,00
( 0,00% )
Vor Marktöffnung: 11:47AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
2,76
Gebot
2,65
Fragen
3,20
Volumen
-
0,00 Tagesbereich 0,00
0,2528 52-Wochen-Bereich 4,4899
Marktkapitalisierung
35,498M
Handelsende
2,76
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.876.042
Ausgegebene Aktien
12.861.605
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-7,63
Gewinn pro Aktie (EPS)
-0,36
Erlöse
111k
Nettogewinn
-4,65M

Über Nexalin Technologies Inc

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Sektor
Electromedical Apparatus
Branche
Electromedical Apparatus
Website
www.nexalin.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Nexalin Technologies Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker NXL. The last closing price for Nexalin Technologies was US$2,76. Over the last year, Nexalin Technologies shares have traded in a share price range of US$ 0,2528 to US$ 4,4899.

Nexalin Technologies currently has 12.861.605 shares in issue. The market capitalisation of Nexalin Technologies is US$35,50 million. Nexalin Technologies has a price to earnings ratio (PE ratio) of -7.63.

NXL Neueste Nachrichten

Weitere Nachrichten

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

HOUSTON, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS) of the...

23 Dezember 2024
GlobeNewswire Inc.

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

HOUSTON, TX, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announces that its proprietary Deep Intracranial Frequency Stimulation...

26 November 2024
GlobeNewswire Inc.

Nexalin Technology CEO Provides Letter to Shareholders

HOUSTON, TX, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today released a letter to shareholders from its CEO Mark White: Dear...

11 November 2024
GlobeNewswire Inc.

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on November 5, 2024, at 4:15...

01 November 2024
GlobeNewswire Inc.

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market...

01 November 2024
GlobeNewswire Inc.

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

HOUSTON, TX, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced publication of a landmark study titled, “Altered...

28 Oktober 2024
GlobeNewswire Inc.

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous Clinical Trial Treating Veterans with Mild Traumatic...

22 Oktober 2024
GlobeNewswire Inc.

New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients

HOUSTON, TX, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced results from a clinical trial demonstrating improvements...

17 Oktober 2024
GlobeNewswire Inc.

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

HOUSTON, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announces the appointment of Carolyn Shelton as Senior Vice President of...

14 Oktober 2024
GlobeNewswire Inc.

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

HOUSTON, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announced its participation in a high-profile Congressional roundtable...

05 September 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.08-2.816901408452.842.982.523481632.86366732CS
4-1.35-32.84671532854.114.392.355056573.44822861CS
122.115327.9069767440.6454.48990.59118760422.63941252CS
261.1268.29268292681.644.48990.5919865012.43632386CS
522.3644597.6744186050.39564.48990.252813333942.02587604CS
1560.062.222222222222.74.48990.25286400851.95751062CS
2600.062.222222222222.74.48990.25286400851.95751062CS

NXL - Frequently Asked Questions (FAQ)

What is the current Nexalin Technologies share price?
The current share price of Nexalin Technologies is US$ 2,76
How many Nexalin Technologies shares are in issue?
Nexalin Technologies has 12.861.605 shares in issue
What is the market cap of Nexalin Technologies?
The market capitalisation of Nexalin Technologies is USD 35,5M
What is the 1 year trading range for Nexalin Technologies share price?
Nexalin Technologies has traded in the range of US$ 0,2528 to US$ 4,4899 during the past year
What is the PE ratio of Nexalin Technologies?
The price to earnings ratio of Nexalin Technologies is -7,63
What is the cash to sales ratio of Nexalin Technologies?
The cash to sales ratio of Nexalin Technologies is 320,93
What is the reporting currency for Nexalin Technologies?
Nexalin Technologies reports financial results in USD
What is the latest annual turnover for Nexalin Technologies?
The latest annual turnover of Nexalin Technologies is USD 111k
What is the latest annual profit for Nexalin Technologies?
The latest annual profit of Nexalin Technologies is USD -4,65M
What is the registered address of Nexalin Technologies?
The registered address for Nexalin Technologies is 1811 SILVERSIDE ROAD, WILMINGTON, DELAWARE, 19810
What is the Nexalin Technologies website address?
The website address for Nexalin Technologies is www.nexalin.com
Which industry sector does Nexalin Technologies operate in?
Nexalin Technologies operates in the ELECTROMEDICAL APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RAINRain Enhancement Technologies Holdco Inc
 11,50
(850,41%)
150
ALCEAlternus Clean Energy Inc
US$ 2,03
(158,34%)
13,33M
AEIAlset Inc
US$ 2,37
(132,35%)
11,54M
CMCTCreative Media and Community Trust Corporation
US$ 0,4437
(97,20%)
28,65M
VRMEVerifyMe Inc
US$ 2,23
(63,97%)
11M
BDMDBaird Medical Investment Holdings Ltd
US$ 4,90
(-35,53%)
244,04k
AIPArteris Inc
US$ 8,01
(-21,39%)
49
BFINBankFinancial Corporation
US$ 10,01
(-21,15%)
9
LNSRLENSAR Inc
US$ 7,15
(-20,02%)
1
VIRCVirco Manufacturing Company
US$ 8,20
(-20,00%)
2
CMCTCreative Media and Community Trust Corporation
US$ 0,4437
(97,20%)
28,65M
SVMHSRIVARU Holding Ltd
US$ 0,0442
(4,99%)
22,06M
CGBSCrown LNG Holdings Ltd
US$ 0,6376
(59,36%)
18,87M
ALCEAlternus Clean Energy Inc
US$ 2,03
(158,34%)
13,33M
AEIAlset Inc
US$ 2,37
(132,35%)
11,54M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
NXL
Nexalin Technologies
BIT
NSCIT7475964
Assicurazioni Generali
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten